Capital Opportunities for Small Businesses - sbtdc

More documents

Recommendations

Info

C A P I T A L O P P O R T U N I T I E S F O R SMA L L B U S I N E S S E S Venture Firm Year Founded Capital Under Management Preferred Stage of Financing Preferred Size of Investment Preferred Industries Website Comments Morgenthaler Ventures 1968 $3 billion All Stages IT: Expects to invest $5 to $15 million total in each company over several rounds. Life Sciences: Expects to invest between $12 and $20 million total in a biotech company over several rounds. Enterprise IT (enterprise software, systems & services); Life Sciences (therapeutic biotech companies, specialty pharmaceuticals, select biotech tools, therapeutic medical devices); Semiconductor & components (optical networking, wireless communications, communications semiconductors); Broadband communications (telecomm equipment & services). NC Bioscience Investment Fund (NCBIF)- c/o Eno River Capital, LLC NC Innovative Development for Economic Advancement (NC IDEA) New Enterprise Associates (NEA) 1998 $26 million Seed & Early Stage $500,000 to $4 million 2005 $1.7 Million Early Stage $10,000-$50,000 1978 $11 billion All Stages, but primarily interested in Start-up/Early Stage $200,000 to $20 million New Atlantic Ventures 1999 $117 million Seed & Early Stage $500,000 to $5 million Life Sciences and Information Technology. Information Technology, Medical Diagnostics, Medical Devices, Material Sciences, and Green Technologies. Information Technology (communications, software & services, electronics, semiconductors) and Healthcare (medical devices, healthcare services, healthcare information systems & services, biopharmaceuticals). Exclusively in Information Technology (communications equipment & software, enterprise software & services, internet infrastructure services). NCBIF focuses on commercializing technology developed at North Carolina's universities and research institutions. 104
PROFILES: VENTURE CAPITAL FUNDS ACTIVE IN NORTH CAROLINA (as of August 2011) Venture Firm Year Founded Capital Under Management Preferred Stage of Financing Preferred Size of Investment Preferred Industries Website Comments Newlight Associates 1997 >$100 million All Stages $1 million to $4 million NextPoint Partners, LP 1990 N/A Seed & Early Stage $250,000 to $4 million Noro-Moseley Partners 1983 $580 million Origin Partners, LP N/A N/A Oxford Bioscience Partners 1992 $1 Billion Seed/Start-up, Early Stage & Growth Stage Early Stage (primarily), but may invest in Later Stage Seed (selective) & Early Stage $3 million to $12 million $2 million or less (looks to invests $3 million to $5 million total per company and participate in all future financing rounds prior to liquidity) Pappas Ventures 1994 >$350 Million Seed to Early Stage $500,000- $5 million Piper Jaffray Ventures N/A $5.2 Billion All Stages $3 million to $10 million Information Technology (esp. software, specialty semiconductors, Internet infrastructure, communications, businessto-business e-commerce). Technology companies, mainly in the software sector (enterprise software & related services, telecommunications, networking, Internet infrastructure, semiconductors). Technology (software, web applications, communications infrastructure (components & systems or other hardware), other); Healthcare (services, life sciences, information technology, devices); Business Services (outsourcing (telecom services, human resources, web services), transaction processing, financial services). Information Technology, Communications, Medical Technology $1 million to $10 million Life Sciences: Bioscience and Healthcare. Life Sciences – Biotechnology, Biopharmaceuticals, Drug Delivery, Medical Devices & Related Ventures Exclusively in Healthcare (medical technology, biotechnology & healthcare services). Invests primarily in the Mid-Atlantic region; has recently invested in NC. Different investment criteria and investment parameters based upon classification of the company by stage. To view firm's classification scheme visit: www.noro-moseley.com/stage.asp Invests primarily in Northeast U.S. and Texas, but will invest elsewhere; has recently invested in NC. The largest share of Pappas’ capital is invested in companies whose lead products are at the Phase 1 or Phase 2 stage of development. Firm is an independent subsidiary of U.S. Bancorp Piper Jaffray. 105
Page 1 and 2:
C A P I T A L O P P O R T U N I T I
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54: C A P I T A L O P P O R T U N I T I
Page 63 and 64: APPENDIX A: QUICK REFERENCE TO SBA
Page 65 and 66: PROGRAM AMOUNT % GUARANTEE (MAX) US
Page 97 and 98: PROFILES: VENTURE CAPITAL FUNDS ACT
Page 103: PROFILES: VENTURE CAPITAL FUNDS ACT
Page 149: C A P I T A L O P P O R T U N I T I
show all

Capital Opportunities for Small Businesses - sbtdc

Create successful ePaper yourself

Delete template?

Save as template?